VivaGel™ (SPL7013 Gel): A candidate dendrimer - Microbicide for the prevention of HIV and HSV infection

International Journal of Nanomedicine

Volumn 2, Issue 4, 2007, Pages 561-566

  Rupp, Richard ^a   Rosenthal, Susan L ^a   Stanberry, Lawrence R ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Dendrimer; Microbicide; SPL7013; VivaGel

Indexed keywords

ACICLOVIR; CARBOMER; DENDRIMER; FOSCARNET; MICROBICIDE; PENCICLOVIR; VIVAGEL; ANTIVIRUS AGENT; POLYLYSINE; TOPICAL ANTIINFECTIVE AGENT;

ANTIVIRAL ACTIVITY; CLINICAL TRIAL; DRUG SAFETY; DRUG TOLERABILITY; HERPES SIMPLEX; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VITRO STUDY; NANOTECHNOLOGY; NONHUMAN; REVIEW; SEXUALLY TRANSMITTED DISEASE; CHEMISTRY;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; SIMPLEXVIRUS;

ANTI-INFECTIVE AGENTS, LOCAL; ANTIVIRAL AGENTS; CLINICAL TRIALS AS TOPIC; DENDRIMERS; HERPES SIMPLEX; HIV INFECTIONS; HUMANS; POLYLYSINE;

EID: 38949198100     PISSN: 11769114     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (12)

1. Abner SR, Guenthner PC, Guarner J, et al. 2005. A human colorectal explant culture to evaluate topical microbicides for the prevention of HIV infection. JID, 192:1545-56.
2. Bernstein DI, Stanberry LR, Sacks S, et al. 2003. Evaluations of unformulated and formulated dendrimer-based microbicide candidates in mouse and guinea pig models of genital herpes. Antimicrob Agents Chemother, 47:3784-8.
3. Dezzutti CS, James VN, Ramos A, et al. 2004. In vitro comparison of topical microbicides for prevention of Human Immunodeficiency Virus type 1 transmission. Antimicrob Agents Chemother, 48:3834-44.
4. Gong E, Matthews B, McCarthy T, et al. 2005. Evaluation of dendrimer SPL7013, a lead microbicide candidate againstheTpes simplexviruses. Antivir Res, 68:139-46.
5. Jiang YH, Emau P, Cairns JS, et al. 2005. SPL7013 gel as a topical microbicide for prevention of vaginal transmission of SHIV 89.6P in Macaques. AIDS Res Hum Retrovir, 21:207-13.
6. McCarthy TD, Karellas P, Henderson SA, et al. 2005. Dendrimers as drugs: discovery and preclinical and clinical development of dendrimer-based microbicides for HIV and STI prevention. Mol Pharm, 2:312-18.
7. Patton DL, Sweeney YT, McCarthy TD, et al. 2006. Preclinical safety and efficacy assessments of dendrimer-based (SPL7013) microbicide gel formulations in a nonhuman primate model. Antimicrob Agents Chemother, 50:1696-700.
8. Starpharma. 2006a. Vivagel fast track status [online].Accessed 18 Aug 2006. URL:http://starpharma.com
9. Starpharma. 2006b. Vivagel is a potent contraceptive in animal model [online]. Accessed 18 Aug 2006. URL:http://starpharma.com
10. Starpharma. 2006c. Vivagel IND for genital herpes trial clears FDA [online]. Accessed 18 Aug 2006. URL:http://starpharma.com
11. Turpin JA. 2002. Considerations and development of topical microbicides to inhibit sexual transmission of HIV. Expert Opin Investig Drugs, 11:1077-97.
12. UNAIDS. 2006. Report on the global AIDS epidemic: May 2006 [online]. URL: http://w3.unaids.org/en/Publications/default.asp